论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Sawyer D, Gates K
Received 4 January 2017
Accepted for publication 26 January 2017
Published 18 April 2017 Volume 2017:8 Pages 27—30
DOI https://doi.org/10.2147/VMRR.S131583
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Lucy Goodman
Peer reviewer comments 2
Editor who approved publication: Professor Young Lyoo
Objective: The objective of this study was to describe a case of severe lamotrigine
toxicosis in a dog, which was successfully treated using minimal medical
interventions.
Case summary: A 7-month-old male, intact, Labrador mix was evaluated
because of acute onset of vomiting, rigidity, and dull mentation after
ingesting lamotrigine tablets. The estimated oral dose that had been ingested
was 278 mg/kg (611.6 mg/lb). Physical examination was unremarkable other than
abnormalities noted in the cardiovascular and neurological systems.
Neurological examination revealed dull mentation, vertical nystagmus,
four-legged extensor limb rigidity, and alligator rolling. Cardiovascular
examination revealed pale pink mucous membranes and multifocal ventricular tachycardia.
Intravenous (IV) fluids were started at three times maintenance (180
mL/kg/day). Methocarbamol (100 mg/kg [220 mg/lb], rectally) and lidocaine
(2 mg/kg [4.4 mg/lb, IV]) were administered. Twenty-four and
seventy-two hours after presentation, the dog was clinically normal with no
ventricular tachycardia being noted.
Conclusion: Lamotrigine
(6-[2,3-dichlorophenyl]-1,2,4-triazine-3,5-diamine) is an anticonvulsant
medication used in humans, which inhibits voltage-gated sodium channels. The
clinical success of this case suggests that administration of only
methocarbamol for the neurologic effects and lidocaine for the arrhythmias, as
well as supportive IV fluid therapy, could be a successful treatment strategy
for dogs, even with severe lamotrigine toxicosis.
Keywords: arrhythmia, toxicity, multifocal
ventricular tachycardia, poison
摘要视频链接:Severe lamotrigine toxicosis in a dog